David E.I. Pyott joined Allergan on January 1, 1998. He refocused the company’s strategy on specialty pharmaceuticals and medical devices creating leading franchises in ophthalmology, neurosciences, medical dermatology, medical aesthetics, urology and other specialty markets, as well as restructuring Allergan’s worldwide operations. Savings from these streamlining programs were reinvested into a major expansion of R&D and sales forces worldwide. In 2002 the ophthalmic surgical device and contact lens care businesses were spun off into Advanced Medical Optics, Inc., a separate, publicly traded company. In March 2006, Allergan acquired Inamed Corp. for over $3 billion to create the world’s largest medical aesthetics company. In 2006, BOTOX® sales, in terms of global in-market demand, exceeded $1 billion. In 2007, Allergan acquired Groupe Laboratoires Cornéal in France (dermal fillers), EndoArt SA in Switzerland (gastric bands), and Esprit Pharma, Inc. (urologics). Allergan has also been the fastest growing global ophthalmic company for the last 6 years.

In 2006, Mr. Pyott was bestowed with the honor of Commander of the Most Excellent Order of the British Empire (CBE) by Her Majesty the Queen in acknowledgment of Mr. Pyott’s contribution to British business excellence and management skills in the United States.

Before joining Allergan, Mr. Pyott served as the Head of the Novartis Nutrition Division and as a member of the Executive Committee of the Switzerland-based Novartis AG. At Novartis and Sandoz, a predecessor company of Novartis, Mr. Pyott worked for 17 years in several positions in strategic planning, marketing and general management in Malaysia, Singapore, Austria, Spain, the United States and Switzerland.

He holds a Diploma in German and European Law from the Europa Institute at the University of Amsterdam, a Master of Arts degree from the University of Edinburgh, and a Master of Business Administration degree from the London Business School.

Mr. Pyott is a member of the Board of Directors of Avery Dennison Corporation and Edwards Lifesciences Corporation. He serves on the Board and the Executive Committee of the California Healthcare Institute, the Directors’ Board of The Paul Merage School of Business at the University of California (Irvine) and the Chief Executive Roundtable for UCI. Mr. Pyott also serves as a member of the Board of the Pan-American Ophthalmological Foundation, the International Council of Ophthalmology Foundation, the Foundation of the American Academy of Ophthalmology Advisory Board, and the Biotechnology Industry Organization and chairs BIO’s Standing Committee on International Affairs.

Mr. Pyott is 55 years old, married, and has four children.